Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

6.940 -0.210 (-2.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,161,905
Open 6.970
Bid (Size) 6.940 (2)
Ask (Size) 6.970 (46)
Prev. Close 7.150
Today's Range 6.870 - 7.125
52wk Range 5.010 - 17.81
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal
BioNTech agreed to buy CureVac for $1.25 billion, expanding its mRNA cancer research and boosting its oncology pipeline. 
Via Benzinga
RFK Jr. Appoints Vaccine Critics To CDC Vaccine Panel After Firing Entire Advisory Committee: Report
Health Secretary Robert F. Kennedy Jr. named eight new members to the CDC's Advisory Committee on Immunization Practices. 
Via Benzinga

Performance

YTD
-19.0%
-19.0%
1 Month
+12.1%
+12.1%
3 Month
-15.1%
-15.1%
6 Month
-23.1%
-23.1%
1 Year
-56.2%
-56.2%

More News

Read More
Novavax's Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Phase 3 Trial
Via Benzinga
Novavax’s Covid-Flu Combo, Standalone Flu Vaccines Demonstrate Robust Immune Response In Late-Stage Trial: Retail Says It’s ‘A Very Good Sign’
Via Stocktwits
Exposures COVID-19 Product Safety
American Pharmacists Association Withholds Endorsement Of CDC's Revised COVID-19 Vaccine Guidance
Via Benzinga
Exposures COVID-19
Vaccine Stocks Alert: Has RFK Jr.'s CDC Panel Shakeup Sent Retail Traders To The Sidelines?
Via Stocktwits
Topics Government
Exposures COVID-19 Political
Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.
Via Investor's Business Daily
Topics Government
Exposures COVID-19 Political
RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Experts
Via Benzinga
Exposures COVID-19
Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals
Via Benzinga
Exposures COVID-19 Product Safety
RFK Jr. Drops COVID Vaccine Recommendation For Healthy Kids, But Experts Warn Of Major Risks
Via Benzinga
Exposures COVID-19
Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effort
Via Benzinga
Topics Government
Exposures Political
Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Children
Via Benzinga
Exposures COVID-19
Analysts Think These Stocks Could More Than Double in Value
Via MarketBeat
Topics World Trade
Exposures Tariff
What's Driving the Market Sentiment Around Novavax?
Via Benzinga
FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr.
Via Benzinga
Exposures COVID-19 Product Safety
FDA Sets New Guidelines For Approving COVID-19 Booster Shots In Healthy Individuals: Moderna, Novavax Stocks Rise
Via Stocktwits
Exposures COVID-19 Product Safety
The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped.
Via Investor's Business Daily
Topics Bankruptcy Government
Exposures COVID-19 Financial Legal
US Stocks Likely To Open Lower After S&P 500's Six-Day Streak: 'Quick Recoveries Tend To See Stocks Rally More Over The Next 3-12 Months,' Says Expert
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Surges Over 100 Points Despite Moody's US Downgrade: Fear Index Remains In 'Greed' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks Mixed, Treasury Bonds Slip On Moody's US Downgrade: What's Driving Markets Monday?
Via Benzinga
Topics Economy
Exposures Economy
Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment
Via Benzinga
Exposures COVID-19 Product Safety
Gapping stocks in Monday's session
Via Chartmill
CI&T, Novavax, Paramount Group And Other Big Stocks Moving Higher On Monday
Via Benzinga

Frequently Asked Questions

Is Novavax, Inc. - Common Stock publicly traded?
Yes, Novavax, Inc. - Common Stock is publicly traded.
What exchange does Novavax, Inc. - Common Stock trade on?
Novavax, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Novavax, Inc. - Common Stock?
The ticker symbol for Novavax, Inc. - Common Stock is NVAX on the Nasdaq Stock Market
What is the current price of Novavax, Inc. - Common Stock?
The current price of Novavax, Inc. - Common Stock is 6.940
When was Novavax, Inc. - Common Stock last traded?
The last trade of Novavax, Inc. - Common Stock was at 06/13/25 04:00 PM ET
What is the market capitalization of Novavax, Inc. - Common Stock?
The market capitalization of Novavax, Inc. - Common Stock is 516.92M
How many shares of Novavax, Inc. - Common Stock are outstanding?
Novavax, Inc. - Common Stock has 517M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.